TAFAZZIN and neoplasm: Similarly, the silencing of TAZ in HeLa cells significantly inhibited tumor growth ability in vivo (Fig 3F, P<0.01); the average tumor weight was 0.36±0.16 g in the HeLa-shTAZ group and 1.09±0.35 g in the HeLa-shControl group (Fig 3E, P<0.01).